Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Lava Therapeutics
An open-label, phase 1 dose escalation trial with disease-specific expansion cohorts to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary anti-tumor activity of LAVA-051 in patients with relapsed or refractory CLL, MM, or AML. The trial was intended to be a Phase 1/2 trial (but the trial never moved forward to Phase 2).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted